# Recida Therapeutics, Inc. — Form D

Recida Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-12. The offering totals $10.7M, of which $5.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-07-12
- Form: D
- Accession: 0001746104-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.7M
- Amount sold: $5.7M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2018-06-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-316724

## Issuer

- Name: Recida Therapeutics, Inc.
- CIK: 0001746104
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 70 WILLOW ROAD, MENLO PARK, CA, 94025
- Phone: 650-325-5156

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Yigong Ge | Director | Menlo Park, CA |
| Patrick Heron | Director | Philadelphia, PA |
| David Socks | Director | Menlo Park, CA |
| Yigong Ge | Executive Officer | Menlo Park, CA |
| Michael Savino | Executive Officer | Fenton, MO |

## More

- [CIK 1746104 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1746104&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001746104-18-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.